QA: SCYNEXIS INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178253_2022_SCYNEXIS_INC.pdf

Logs

Graph

Absolute values for 0001178253, SCYNEXIS INC

  xvar xval
0 AssetsCurrent 109,377,000
1 IntangibleAssetsNetIncludingGoodwill 1,056,000
2 PropertyPlantAndEquipmentNet 113,000
3 remainder_Assets 9,291,000
4 LiabilitiesCurrent 13,616,000
5 LiabilitiesNoncurrent 6,549,000
6 remainder_Liabilities 58,414,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 49,916,000
9 ResearchAndDevelopmentExpense 23,773,000
10 remainder_Expenses -2,776,000
11 remainder_Revenues 13,163,000
12 remainder_NetIncome 24,884,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 119,837,000
1 Liabilities 78,579,000
2 Expenses 70,913,000
3 Revenues 13,163,000
4 StockholdersEquity 41,258,000
5 NetIncome -32,866,000
6 ComprehensiveNetIncome -32,866,000
7 BaseVar 153,688,000
8 EconomicCapitalRatio 0.384

Edgar->Model Mapping

Feature Distribution

Change over Time